Retrieve available abstracts of 16 articles: HTML format
Single Articles
September 2025
NATHANSON SD, Dieterich LC, Zhang XH, Chitale DA, et al Correction: Associations amongst genes, molecules, cells, and organs in breast
cancer metastasis.
Clin Exp Metastasis. 2025;42:55. PubMed
August 2025
ZHANG W, Rahman S, Wu AML, Isanogle K, et al A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain
metastases in hematogenous preclinical models.
Clin Exp Metastasis. 2025;42:45. PubMedAbstract available
July 2025
BINDEMAN WE, Corn KC, Rafat M, Fingleton B, et al Loss of IL13RA2 promotes metastatic tumor growth in triple-negative breast cancer
via increased AKT and NF-kappaB signaling.
Clin Exp Metastasis. 2025;42:40. PubMedAbstract available
May 2025
RUSSANO F, Corrado G, Bonadies A, Migliano E, et al Prospective multicentre study of patients with cutaneous metastases from breast
cancer treated with electrochemotherapy.
Clin Exp Metastasis. 2025;42:32. PubMedAbstract available
April 2025
ROQUET N, Beddok A, Loo M, Calais G, et al Post-operative hypofractionated stereotactic radiotherapy for brain metastases
from lung and breast cancer in patients without prior WBRT: a retrospective dose
escalation study.
Clin Exp Metastasis. 2025;42:27. PubMedAbstract available
CHEN L, Chow A, Ma W, Coker C, et al A new, immunocompetent brain-metastatic mouse model of HER2-positive breast
cancer.
Clin Exp Metastasis. 2025;42:25. PubMedAbstract available
LIANG H, Yin G, Feng D, Shi G, et al Ras-proximate-1 (RAP1): a prognosis and therapeutic target in the metastatic
spread of breast cancer.
Clin Exp Metastasis. 2025;42:23. PubMedAbstract available
December 2024
FABIAN A, Buergy D, Weykamp F, Horner-Rieber J, et al Metastasis-directed stereotactic radiotherapy in patients with breast cancer:
results of an international multicenter cohort study.
Clin Exp Metastasis. 2024;42:6. PubMedAbstract available
September 2024
MERLONI F, Palleschi M, Gianni C, Sirico M, et al Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy,
toxicities and future perspectives.
Clin Exp Metastasis. 2024 Sep 23. doi: 10.1007/s10585-024-10312. PubMedAbstract available
ZHENG Q, Zhou T, Ding W Efficacy and safety of PARPis combined with an ICIs for advanced or metastatic
triple-negative breast cancer: a single-arm meta-analysis.
Clin Exp Metastasis. 2024 Sep 4. doi: 10.1007/s10585-024-10307. PubMedAbstract available
June 2024
CHEN K, Dong Y, He G, He X, et al UBTF mediates activation of L3MBTL2 to suppress NISCH expression through histone
H2AK119 monoubiquitination modification in breast cancer.
Clin Exp Metastasis. 2024 Jun 27. doi: 10.1007/s10585-024-10299. PubMedAbstract available
GRUBE M, Dimmler A, Schmaus A, Saup R, et al Ketogenic diet does not promote triple-negative and luminal mammary tumor growth
and metastasis in experimental mice.
Clin Exp Metastasis. 2024;41:251-266. PubMedAbstract available
May 2024
BAUGH AG, Gonzalez E, Narumi VH, Kreger J, et al A new Neu-a syngeneic model of spontaneously metastatic HER2-positive breast
cancer.
Clin Exp Metastasis. 2024 May 8. doi: 10.1007/s10585-024-10289. PubMedAbstract available
April 2024
BHAT V, Piaseczny M, Goodale D, Patel U, et al Lung-derived soluble factors support stemness/plasticity and metastatic behaviour
of breast cancer cells via the FGF2-DACH1 axis.
Clin Exp Metastasis. 2024 Apr 6. doi: 10.1007/s10585-024-10284. PubMedAbstract available
March 2024
LEDUC S, Nguyen HL, Richard F, Zels G, et al Transcriptomic characterization of the histopathological growth patterns in
breast cancer liver metastases.
Clin Exp Metastasis. 2024 Mar 29. doi: 10.1007/s10585-024-10279. PubMedAbstract available
LIBRING S, Berestesky ED, Reinhart-King CA The movement of mitochondria in breast cancer: internal motility and
intercellular transfer of mitochondria.
Clin Exp Metastasis. 2024 Mar 15. doi: 10.1007/s10585-024-10269. PubMedAbstract available